miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53

(1) Background: To examine miR-429-meditated DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 (DDX53) function in endometrial cancer (EC). (2) Methods: DDX53 and miR-429 levels were measured using quantitative real-time polymerase chain reaction and western blotting assays, cell invasion and migration usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyung-Jun, Singh, Nitya, Bizuneh, Michael, Kim, Nam-Hyeok, Kim, Hyeong Su, Kim, Youngmi, Lee, Jae-Jun, Kim, Jung Han, Kim, Jiye, Jeong, Soo Young, Cho, Hye-Yon, Park, Sung Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532590/
https://www.ncbi.nlm.nih.gov/pubmed/37763070
http://dx.doi.org/10.3390/jpm13091302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532590/
https://www.ncbi.nlm.nih.gov/pubmed/37763070
http://dx.doi.org/10.3390/jpm13091302

Ejemplares similares